Dossier

QUINOXALINEDIONE AND PYRIDO[2,3-B]PYRAZINE-2,3-DIONE B CELL LYMPHOMA 6 (BCL6) DEGRADERS AND USES THEREOF

InventionPending

11views

58Claims · 10 independent

§ Ⅰ

Dossier Overview

Applicant

DANA-FARBER CANCER INSTITUTE, INC.

Inventor

Lyn Howard JONES; Jianwei CHE; Huang HUANG; Nikki KONG; Justin CRUITE; Yingpeng LIU

IPC Classification

C7D 401/14A61K 31/498A61K 31/506A61K 45/6C7D 405/14C7D 409/14C7D 413/14C7D 471/4

CPC Classification

C7D401/14A61K31/498A61K31/506A61K45/6C7D405/14C7D409/14C7D413/14C7D471/4

Described are the compounds, compositions and methods of treating a cancer characterized by aberrant B-cell lymphoma 6 (BCL6) activity.

Original (Chinese)

Described are the compounds, compositions and methods of treating a cancer characterized by aberrant B-cell lymphoma 6 (BCL6) activity.

External Resources